Association between serum endogenous secretory receptor for advanced glycation end products and risk of type 2 diabetes mellitus with combined depression in the Chinese population

Diabetes Technology and Therapeutics

Volumn 14, Issue 10, 2012, Pages 936-942

  Chen, Gang ^a   Wu, Yulian ^b   Wang, Tao ^a   Liang, Jixing ^a   Lin, Wei ^a   Li, Liantao ^a   Wen, Junping ^a   Lin, Lixiang ^a   Huang, Huibin ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF XIAMEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; ALBUMIN; C REACTIVE PROTEIN; HEMOGLOBIN A1C; LIPID;

ADULT; AGE DISTRIBUTION; AGED; ARTERIAL WALL THICKNESS; ARTICLE; BODY MASS; CAROTID ARTERY; CHINESE; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; FEMALE; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POPULATION RISK; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN URINE LEVEL; RISK ASSESSMENT; SEX DIFFERENCE; URINE LEVEL; WAIST CIRCUMFERENCE;

ADULT; AGE DISTRIBUTION; AGED; ALBUMINURIA; ASIAN CONTINENTAL ANCESTRY GROUP; ATHEROSCLEROSIS; C-REACTIVE PROTEIN; CAROTID INTIMA-MEDIA THICKNESS; CHINA; COMORBIDITY; CROSS-SECTIONAL STUDIES; DEPRESSION; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RECEPTORS, IMMUNOLOGIC; RISK FACTORS; SEX DISTRIBUTION;

EID: 84867055020     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2012.0072     Document Type: Article

References (42)

1. Petrak F, Hautzinger M, Plack K, Kronfeld K, Ruckes C, Herpertz S, Müller MJ: Cognitive behavioural therapy in elderly type 2 diabetes patients with minor depression or mild major depression: study protocol of a randomized controlled trial (MIND-DIA). BMC Geriatr 2010;10:21-29.
2. Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, Clouse RE: Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 2000; 23:934-942.
3. Simon GE, Katon WJ, Lin EH, Ludman E, VonKorff M, Ciechanowski P, Young BA: Diabetes complications and depression as predictors of health service costs. Gen Hosp Psychiatry 2005;27:344-351.
4. Ali S, Stone MA, Peters JL, Davies MJ, Khunti K: The prevalence of co-morbid depression in adults with type 2 diabetes: a systematic review and meta-analysis. Diabet Med 2006;23:1165-1173.
5. Wexler DJ, Grant RW, Wittenberg E, Bosch JL, Cagliero E, Delahanty L, Blais MA, Meigs JB: Correlates of healthrelated quality of life in type 2 diabetes. Diabetologia 2006;49:1489-1497.
6. Zhang CX, Chen YM, Chen WQ: Association of psychosocial factors with anxiety and depressive symptoms in Chinese patients with type 2 diabetes. Diabetes Res Clin Pract 2008; 79:523-530.
7. Kokoszka A, Pouwer F, Jodko A, Radzio R, Muko P, Bieńkowska J, Kuligowska E, Smoczyńska O, Skodowska Z: Serious diabetes-specific emotional problems in patientswith type 2 diabetes who have different levels of comorbid depression: a Polish study fromthe EuropeanDepression inDiabetes (EDID) Research Consortium. Eur Psychiatry 2009;24:425-430.
8. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ: The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001;24:1069-1078.
9. Pizzi C, Manzoli L, Mancini S, Bedetti G, Fontana F, Costa GM: Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors. Atherosclerosis 2010;212:292-298.
10. Seldenrijk A, vanHoutHP, vanMarwijkHW, deGroot E, Gort J,RustemeijerC,DiamantM, PenninxBW:Depression, anxiety, and arterial stiffness. Biol Psychiatry 2011;69:795-803.
11. Ford DE, Erlinger TP: Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 2004;164:1010-1014.
12. Pizzi C, Mancini S, Angeloni L, Fontana F, Manzoli L, Costa GM: Effects of selective serotonin reuptake inhibitor therapy on endothelial function and inflammatory markers in patients with coronary heart disease. Clin Pharmacol Ther 2009;86:527-532.
13. Bruce EC, Musselman DL: Depression, alterations in platelet function, and ischemic heart disease. Psychosom Med 2005;67(Suppl 1):S34-S36.
14. Seldenrijk A, Vogelzangs N, van Hout HP, van Marwijk HW, Diamant M, Penninx BW: Depressive and anxiety disorders and risk of subclinical atherosclerosis. Findings from the Netherlands Study of Depression and Anxiety (NESDA). J Psychosom Res 2010;69:203-210.
15. Black SA: Diabetes, diversity, and disparity: what do we do with the evidence? Am J Public Health 2002;92:543-548.
16. Makine C, Karida C, Kadiolu P, Ilkova H, Karida K, Skovlund SE, Snoek FJ, Pouwer F: Symptoms of depression and diabetes-specific emotional distress are associated with a negative appraisal of insulin therapy in insulin-naive patients with Type 2 diabetes mellitus. A study from the European Depression in Diabetes [EDID] Research Consortium. Diabet Med 2009;26:28-33.
17. Hori O, Brett J, Slattery T, Cao R, Zhang J, Chen JX, Nagashima M, Lundh ER, Vijay S, Nitecki D, Morser J, Stern D, Schmidt AM: The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J Biol Chem 1995;270:25752-25761.
18. Basta G: Receptor for advanced glycation endproducts and atherosclerosis: from basic mechanisms to clinical implications. Atherosclerosis 2008;196:9-21.
19. Grossin N, Wautier MP, Meas T, Guillausseau PJ, Massin P, Wautier JL: Severity of diabetic microvascular complications is associated with a low soluble RAGE level. Diabetes Metab 2008;34:392-395.
20. Schmidt AM, Yan SD, Yan SF, Stern DM: The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest 2001;108: 949-955.
21. Yonekura H, Yamamoto Y, Sakurai S, Petrova RG, Abedin MJ, Li H, Yasui K, Takeuchi M, Makita Z, Takasawa S, Okamoto H, Watanabe T, Yamamoto H: Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury. Biochem J 2003;370:1097-1109.
22. Hudson BI, Harja E, Moser B, Schmidt AM: Soluble levels of receptor for advanced glycation endproducts (sRAGE) and coronary artery disease: the next C-reactive protein? Arter-ioscler Thromb Vasc Biol 2005;25:879-882.
23. Williams JB, Gibbon M, First MB, Spitzer RL, Davies M, Borus J, Howes MJ, Kane J, Pope HG Jr, Rounsaville B, Wittchen HU: The structured clinical interview for DSM-IIIR (SCID). II. Multisite test-retest reliability. Arch Gen Psychiatry 1992;49:630-636.
24. McIntyre RS, Konarski JZ, Mancini DA, Fulton KA, Parikh SV, Grigoriadis S, Grupp LA, Bakish D, Filteau MJ, Gorman C, Nemeroff CB, Kennedy SH: Measuring the severity of depression and remission in primary care: validation of the HAMD-7 scale. CMAJ 2005;173:1327-1334.
25. Ballesteros J, Bobes J, Bulbena A, Luque A, Dal-Ré R, Ibarra N, Güemes I: Sensitivity to change, discriminative performance, and cutoff criteria to define remission for embedded short scales of the Hamilton Depression Rating Scale (HAMD). J Affect Disord 2007;102:93-99.
26. Egede LE, Zheng D, Simpson K: Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care 2002;25:464-470.
27. Katon W, von Korff M, Ciechanowski P, Russo J, Lin E, Simon G, Ludman E, Walker E, Bush T, Young B: Behavioral and clinical factors associated with depression among individuals with diabetes. Diabetes Care 2004;27:914-920.
28. Engum A, Mykletun A, Midthjell K, Holen A, Dahl AA: Depression and diabetes: a large population-based study of sociodemographic, lifestyle, and clinical factors associated with depression in type 1 and type 2 diabetes. Diabetes Care 2005;28:1904-1909.
29. BellRA, SmithSL,ArcuryTA, SnivelyBM, StaffordJM,Quandt SA: Prevalence and correlates of depressive symptoms among rural older African Americans, Native Americans, and whites with diabetes. Diabetes Care 2005;28:823-829.
30. Nair M, Prabhakaran D, Narayan KM, Sinha R, Lakshmy R, Devasenapathy N, Daniel CR, Gupta R, George PS, Mathew A, Tandon N, Reddy KS: HbA1c values for defining diabetes and impaired fasting glucose in Asian Indians. Prim Care Diabetes 2011;5:95-102.
31. Williams LH, Miller DR, Fincke G, Lafrance JP, Etzioni R, Maynard C, Raugi GJ, Reiber GE: Depression and incident lower limb amputations in veterans with diabetes. J Diabetes Complications 2011;25:175-182.
32. Danner M, Kasl SV, Abramson JL, Vaccarino V: Association between depression and elevated C-reactive protein. Psychosom Med 2003;65:347-356.
33. Penninx BW, Kritchevsky SB, Yaffe K, Newman AB, Simonsick EM, Rubin S, Ferrucci L, Harris T, Pahor M: Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition study. Biol Psychiatry 2003;54:566-572.
34. Maes M: Depression is an inflammatory disease, but cell-mediated immuneactivation is the keycomponent of depression. Prog Neuropsychopharmacol Biol Psychiatry 2011;35:664-675.
35. Halder I, Marsland AL, Cheong J, Muldoon MF, Ferrell RE, Manuck SB: Polymorphisms in the CRP gene moderate an association between depressive symptoms and circulating levels of C-reactive protein. Brain Behav Immun 2010;24:160-167.
36. Van der Kooy K, van Hout H, Marwijk H, Marten H, Stehouwer C, Beekman A: Depression and the risk for cardiovascular diseases: systematic review and meta analysis. Int J Geriatr Psychiatry 2007;22:613-626.
37. Nicholson A, Kuper H, Hemingway H: Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J 2006;27:2763-2774.
38. Basta G, Schmidt AM, De Caterina R: Advanced glycation end products and vascular inflammation: implications for acceleratedatherosclerosis indiabetes.Cardiovasc Res 2004;63:582-592.
39. Poredos P: Intima-media thickness: indicator of cardiovascular risk and measure of the extent of atherosclerosis. Vasc Med 2004;9:46-54.
40. Katakami N, Matsuhisa M, Kaneto H, Matsuoka TA, Sakamoto K, Yasuda T, Umayahara Y, Kosugi K, Yamasaki Y: Serum endogenous secretory RAGE level is an independent risk factor for the progression of carotid atherosclerosis in type 1 diabetes. Atherosclerosis 2009;204:288-292.
41. Emanuele E, Martinelli V, Carlin MV, Fugazza E, Barale F, Politi P: Serum levels of soluble receptor for advanced glycation endproducts (sRAGE) in patients with different psychiatric disorders. Neurosci Lett 2011;487:99-102.
42. Subramaniam M, Sum CF, Pek E, Stahl D, Verma S, Liow PH, Chua HC, Abdin E, Chong SA: Comorbid depression and increased health care utilisation in individuals with diabetes. Gen Hosp Psychiatry 2009;3:220-224.